Your browser doesn't support javascript.
loading
Aß and cognitive change: examining the preclinical and prodromal stages of Alzheimer's disease.
Lim, Yen Ying; Maruff, Paul; Pietrzak, Robert H; Ellis, Kathryn A; Darby, David; Ames, David; Harrington, Karra; Martins, Ralph N; Masters, Colin L; Szoeke, Cassandra; Savage, Greg; Villemagne, Victor L; Rowe, Christopher C.
Afiliação
  • Lim YY; The Florey Institute of Neuroscience and Mental Health, Parkville, Victoria, Australia; Department of Psychiatry, The University of Melbourne, Parkville, Victoria, Australia. Electronic address: yen_ying_lim@brown.edu.
  • Maruff P; The Florey Institute of Neuroscience and Mental Health, Parkville, Victoria, Australia; CogState Ltd., Melbourne, Victoria, Australia.
  • Pietrzak RH; Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.
  • Ellis KA; The Florey Institute of Neuroscience and Mental Health, Parkville, Victoria, Australia; Academic Unit for Psychiatry of Old Age, Department of Psychiatry, The University of Melbourne, Kew, Victoria, Australia; National Ageing Research Institute, Parkville, Victoria, Australia.
  • Darby D; The Florey Institute of Neuroscience and Mental Health, Parkville, Victoria, Australia.
  • Ames D; Academic Unit for Psychiatry of Old Age, Department of Psychiatry, The University of Melbourne, Kew, Victoria, Australia; National Ageing Research Institute, Parkville, Victoria, Australia.
  • Harrington K; The Florey Institute of Neuroscience and Mental Health, Parkville, Victoria, Australia.
  • Martins RN; Centre of Excellence for Alzheimer's Disease Research and Care, School of Exercise, Biomedical, and Health Sciences, Edith Cowan University, Perth, Western Australia, Australia.
  • Masters CL; The Florey Institute of Neuroscience and Mental Health, Parkville, Victoria, Australia.
  • Szoeke C; The Florey Institute of Neuroscience and Mental Health, Parkville, Victoria, Australia; National Ageing Research Institute, Parkville, Victoria, Australia; CSIRO Preventative Health Flagship, Parkville, Victoria, Australia.
  • Savage G; Department of Psychology and ARC Centre of Excellence in Cognition and Its Disorders, Macquarie University, Sydney, New South Wales, Australia.
  • Villemagne VL; The Florey Institute of Neuroscience and Mental Health, Parkville, Victoria, Australia; Department of Nuclear Medicine and Centre for PET, Austin Health, Heidelberg, Victoria, Australia; Department of Medicine, Austin Health, The University of Melbourne, Heidelberg, Victoria, Australia.
  • Rowe CC; Department of Nuclear Medicine and Centre for PET, Austin Health, Heidelberg, Victoria, Australia; Department of Medicine, Austin Health, The University of Melbourne, Heidelberg, Victoria, Australia.
Alzheimers Dement ; 10(6): 743-751.e1, 2014 Nov.
Article em En | MEDLINE | ID: mdl-24589436
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Peptídeos beta-Amiloides / Transtornos Cognitivos / Doença de Alzheimer / Sintomas Prodrômicos / Transtornos da Memória Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male Idioma: En Ano de publicação: 2014 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Peptídeos beta-Amiloides / Transtornos Cognitivos / Doença de Alzheimer / Sintomas Prodrômicos / Transtornos da Memória Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male Idioma: En Ano de publicação: 2014 Tipo de documento: Article